← Back to patent-cliff list
CAS 641569-96-2
ethyl 3-guanidino-4-methylbenzoate nitrate
Codes: RADO-002
Application context (from source-drug indications)
Chronic myeloid leukaemiaRadotinib DihydrochloridePhiladelphia chromosomeRadotinib DihydrochlorideChronic-phase myeloid leukaemiaRadotinib DihydrochlorideMyeloid leukaemiaRadotinib DihydrochlorideParkinson's diseaseRadotinib DihydrochlorideLeukaemiaRadotinib Dihydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Radotinib Dihydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ethyl 3-amino-4-methylbenzoate→ethyl 3-guanidino-4-methylbenzoate nitrate→(E)-3-(dimethylamino)-1-(pyrazin-2-yl)prop-2-en-1-one→ethyl 4-methyl-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzoate→4-methyl-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzoic acid→3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline→3-bromo-5-(trifluoromethyl)aniline→4-methyl-1H-imidazole
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | 3-[(Aminoiminomethyl)amino] -4-methylbenzoic acid ethyl ester mononitrate Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.